From: Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals
Categorical time
Number of individuals
Average time (days)
GMT (reciprocal dilution)
RV (30–45 days)
45
40 (30–69)
347
RV (1–5 years)
47
1017 (365–1825)
180
RV (5–9 years)
34
2287 (2190–2555)
177
RV (> 10 years)
9
3163 (2920–5840)
116